Skip to main content
Download PDF

Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

Trials volume 20, Article number: 368 (2019) Cite this article

The Original Article was published on 15 January 2019

Correction to: Trials (2019) 20:49.

https://doi.org/10.1186/s13063-018-3169-3

Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.

  • Incorrect name tagging:

    Last Name: Pasqua.

    First Name: Oscar Della.

  • Correct author name tagging:

    Last Name: Della Pasqua.

    First Name: Oscar.

Reference

  1. Leeuw, et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20:49. https://doi.org/10.1186/s13063-018-3169-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Pain Medicine, Erasmus MC-Sophia Children’s Hospital, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands

    Thomas G. de Leeuw

  2. Consorzio per Valutazione Biologiche e Farmacologiche, Pavia, Italy

    Laura Mangiarini & Adriana Ceci

  3. Fondazione Penta Onlus, Padova, Italy

    Rebecca Lundin

  4. Department of Pediatric Pharmacology and Pharmacogenetics, AP-HP, Hôpital Robert Debré, F-75019, Paris, France

    Florentia Kaguelidou

  5. Inserm, CIC 1426, F-75019, Paris, France

    Florentia Kaguelidou

  6. Université Paris Diderot, Sorbonne Paris Cité, EA 08, F-75010, Paris, France

    Florentia Kaguelidou

  7. Intensive Care and Department of Paediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Dr. Molewaterplein, 40 3015 GD, Rotterdam, The Netherlands

    Tjitske van der Zanden, Dick Tibboel & Saskia N. de Wildt

  8. University College London, London, UK

    Oscar Della Pasqua

  9. Department of Pharmacology and Toxicology, Radboud University, Nijmegen, The Netherlands

    Saskia N. de Wildt

Authors
  1. Thomas G. de Leeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Mangiarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebecca Lundin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Florentia Kaguelidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tjitske van der Zanden
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Oscar Della Pasqua
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dick Tibboel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Adriana Ceci
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Saskia N. de Wildt
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the GAPP consortium

Corresponding author

Correspondence to Thomas G. de Leeuw.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Leeuw, T.G., Mangiarini, L., Lundin, R. et al. Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials 20, 368 (2019). https://doi.org/10.1186/s13063-019-3519-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13063-019-3519-9

Trials

ISSN: 1745-6215